Allstate Corp Seagen Inc. Transaction History

Allstate Corp

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	SELL	$117.37 - $139.17 $127,229 - $150,860	-1,084 Reduced 14.87%	6,207 $797,000
Q2 2022 Aug 15, 2022	BUY	$108.81 - $179.33 $355,155 - $585,333	3,264 Added 81.05%	7,291 $1.29 Million
Q1 2022 May 16, 2022	SELL	$119.61 - $157.85 $80,258 - $105,917	-671 Reduced 14.28%	4,027 $580,000
Q4 2021 Feb 15, 2022	BUY	$142.57 - $190.86 $23,951 - $32,064	168 Added 3.71%	4,698 $726,000
Q3 2021 Nov 15, 2021	SELL	$142.45 - $169.82 $24,501 - $29,209	-172 Reduced 3.66%	4,530 $769,000

Q2 2021 Aug 16, 2021	BUY	$135.08 - $161.1 $58,219 - $69,434	431 Added 10.09%	4,702 $742,000
Q1 2021 May 14, 2021	SELL	$137.51 - $190.8 $151,261 - $209,880	-1,100 Reduced 20.48%	4,271 $593,000
Q4 2020 Feb 12, 2021	BUY	$164.63 - $211.93 $884,227 - $1.14 Million	5,371 New	5,371 $941,000

1.26M

23K

55.2K

Ticker SGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,664,992
Description
Seagen Inc., a biotechnology company, develops and commercializes therapies for the treatment of cancer in the United States and internationally. The company offers ADCETRIS, an antibody-drug conjugate (ADC) for the treatment of patients with Hodgkin lymphoma or CD30-positive T-cell lymphomas; PADCEV, an ADC targeting Nectin-4 for the treatment ...

Get notified when there are updates to the investment portfolio of Allstate Corp, based on Form 13F filings with the SEC.

Stay updated on Allstate Corp with notifications on news.